Cargando…
Bioinformatic analysis linking genomic defects to chemosensitivity and mechanism of action
A joint analysis of the NCI60 small molecule screening data, their genetically defective genes, and mechanisms of action (MOA) of FDA approved cancer drugs screened in the NCI60 is proposed for identifying links between chemosensitivity, genomic defects and MOA. Self-Organizing-Maps (SOMs) are used...
Autor principal: | Covell, David G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081165/ https://www.ncbi.nlm.nih.gov/pubmed/33909629 http://dx.doi.org/10.1371/journal.pone.0243336 |
Ejemplares similares
-
Bioinformatic Analysis of GLI1 and Related Signaling Pathways in Chemosensitivity of Gastric Cancer
por: Yu, Tao, et al.
Publicado: (2018) -
Bioinformatic Analysis of Patient-Derived ASPS Gene Expressions and ASPL-TFE3 Fusion Transcript Levels Identify Potential Therapeutic Targets
por: Covell, David G., et al.
Publicado: (2012) -
Data Mining Approaches for Genomic Biomarker Development: Applications Using Drug Screening Data from the Cancer Genome Project and the Cancer Cell Line Encyclopedia
por: Covell, David G.
Publicado: (2015) -
Bioinformatic analysis of the molecular mechanisms underlying the progression of bone defects
por: Liu, Hao, et al.
Publicado: (2023) -
Predictors of Chemosensitivity in Triple Negative Breast Cancer: An Integrated Genomic Analysis
por: Jiang, Tingting, et al.
Publicado: (2016)